READ THE LATEST

Catch up what you missed in longevity news, anti-aging research & the fast-growing world of biohacking.

Aug 22, 2026

•

7 min read

🏃‍➡️ The Molecular Case for Cardio

A new study shows cardiorespiratory improvements directly slow down epigenetic aging at the molecular level. Plus: the FDA's Alzheimer's drug decision is Monday, great progress in repairing damaged hearts, and the A-team of longevity scientists come together in one virtual room you can join.

Stayin' Alive Media

For Decades We Were Told to Avoid Full-Fat Dairy. New Research Disagrees 🧈

Aug 15, 2026

•

4 min read

For Decades We Were Told to Avoid Full-Fat Dairy. New Research Disagrees 🧈

A 12-week study found three daily servings of full-fat dairy didn't worsen weight, cholesterol, or insulin resistance - and even improved blood pressure. Plus: a thymus hormone that reverses age-related inflammation in mice, and why Apple is racing to catch up with Whoop and Oura.

Stayin' Alive Media

Aug 9, 2026

•

4 min read

Colombia, The Next Blue Zone? 🌎

A new biodemographic analysis found Colombian municipalities with centenarian rates rivaling Okinawa and Sardinia. Plus: a Cell paper argues we've been studying the wrong sex to understand aging, and everything you need to know about an environmental toxins test.

Stayin' Alive Media

Aug 2, 2026

•

4 min read

FDA Loosens Restrictions On Peptides 💉

A key FDA panel voted to loosen restrictions on six peptides biohackers already use - over its own scientists' objections. Plus: a liver drug's real fibrosis-reversal data, and Wall Street's wild reaction to the peptide news.

Stayin' Alive Media

The Case for Treating Inflammation Like Cholesterol 🫀

Jul 26, 2026

•

7 min read

The Case for Treating Inflammation Like Cholesterol 🫀

BioAge just dosed its first patient in a Phase 2 trial testing whether a daily pill can lower cardiovascular risk by targeting inflammation. Plus: Bryan Johnson's autoimmune diagnosis takes a strange turn, and a $100M bet on the future of longevity in the UAE.

Stayin' Alive Media

Ozempic Just Got a Lot More Interesting 💊

Jul 20, 2026

•

6 min read

Ozempic Just Got a Lot More Interesting 💊

First clinical evidence that semaglutide may slow biological aging. Plus: FDA approves lecanemab for home self-injection, and the Mediterranean diet just got a new molecular explanation.

Stayin' Alive Media

Jul 13, 2026

•

7 min read

100 And Counting

Scientists analyzed the blood of centenarians from the New England Centenarian Study and found a consistent set of metabolic patterns. Plus: the year's biggest Alzheimer's data event opens today in London.

Stayin' Alive Media

🧠 How Brain Cells Die (And How To Fight It)

Jul 8, 2026

•

6 min read

🧠 How Brain Cells Die (And How To Fight It)

Scientists just discovered karyoptosis - a previously unknown way neurons die in Alzheimer's and FTD. Plus: Big Pharma drops $140M on thymus rejuvenation, and Superpower tests 100+ biomarkers for $199.

Stayin' Alive Media

What concierge clinics charge $15,000 for, Superpower charges $199. 100+ biomarkers, a personalized action plan, and 24/7 access to a care team.

$20 OFF with code STAYIN20OFF

READ THE LATEST

🏃‍➡️ The Molecular Case for Cardio

For Decades We Were Told to Avoid Full-Fat Dairy. New Research Disagrees 🧈

Colombia, The Next Blue Zone? 🌎

FDA Loosens Restrictions On Peptides 💉

The Case for Treating Inflammation Like Cholesterol 🫀

Ozempic Just Got a Lot More Interesting 💊

100 And Counting

🧠 How Brain Cells Die (And How To Fight It)

Live longer. Live smarter.